fr

The EBMT Trainee Committee

Trainee Pearls

Welcome to “Trainee Pearls”, a new initiative brought to you by the EBMT Trainee Committee to deliver the most important messages (“the pearls”) of high-profile research works in hematology and bone marrow transplant to our fellow trainees all over the world. The topics will span from classical hematology to more focused bone marrow transplant research. The selected research article will be discussed directly with young authors who have been involved with the published work.

N'hésitez pas à visiter le site du podcast et à soutenir son créateur : podcasters.spotify.com

Auteur

The EBMT Trainee Committee

Catégorie

Health

Site du podcast

podcasters.spotify.com

Dernier épisode

29 oct. 2023

Où écouter ?

Les podcasts dans l'appli Replaio Radio Bientôt disponible

Les podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts

Télécharger sur Google Play Installe-la gratuitement Android près de 10 M de téléchargements · note de 4,8 iOS bientôt

Épisodes

#18 Jurjen Versluis: Transplant for high-risk MDS 29.10.2023

Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival. The authors evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. https://pubmed.ncbi.nlm.nih.gov/37607457/ ALSO AS VIDEO ON https://youtu.be/JbHS_-2sJQc CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://w...

#17 Nathanial Anderson: Signatures and persistence of CAR-T cells 05.09.2023

In this study, Nathanial and colleagues systematically analyzed CD19 CAR-T cells of 10 children with R/R B-ALL enrolled in the CARPALL trial via high-throughput single-cell gene expression and T cell receptor sequencing of infusion products and serial blood and bone marrow samples up to 5 years after infusion. Article: https://www.nature.com/articles/s41591-023-02415-3 As VIDEO on https://youtu.be...

#16 Aina Oliver-Caldés: Academic CAR-T cells for myeloma 14.07.2023

Chimeric antigen receptor (CAR) T-cell therapy is a promising option for patients with heavily treated multiple myeloma. Point-of-care manufacturing can increase the availability of these treatments worldwide. Aina and colleagues assessed the safety and activity of ARI0002h, a BCMA-targeted CAR T-cell therapy developed by academia, in patients with relapsed or refractory multiple myeloma. https://...

#15 Francesca del Bufalo: CAR-T cells for neuroblastoma 20.05.2023

Immunotherapy with chimeric antigen receptor (CAR)–expressing T cells that target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for patients with high-risk neuroblastoma. In an academic, phase 1–2 clinical trial, the investigators enrolled patients (1 to 25 years of age) with relapsed or refractory, high-risk neuroblastoma in order to test autologous, third-genera...

#12 Justin Loke: Cytogenetics and TP53 in BMT for AML 05.12.2022

The presence of TP53 mutations is associated with an unfavorable outcome  in patients allografted for acute myeloid leukemia (AML), leading some  to question the benefit of an allogeneic stem cell transplantation  (allo-SCT) for this patient group, although this has not been studied in  a large cohort.  Article: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr....

#11 Ferran Nadeu: Early seeding of Richter transformation 22.09.2022

Richter transformation (RT) is a paradigmatic evolution of chronic  lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma  conferring a dismal prognosis. The mechanisms driving RT remain largely  unknown.   Article: https://www.nature.com/articles/s41591-022-01927-8   ALSO AS AUDIO ON https://podcasts.apple.com/us/podcast/trainee-pearls/id1596786132 ...

#10 Elsa Bernard: IPSS-M in MDS 23.08.2022

Risk stratification and therapeutic decision-making for myelodysplastic syndromes (MDS) are based on the International Prognostic Scoring System–Revised (IPSS-R), which considers hematologic parameters and cytogenetic abnormalities. Somatic gene mutations are not yet used in the risk stratification of patients with MDS. Combining genomic profiling with hematologic and cytogenetic parameters, the I...

#9 Alice Bertaina: Stem cell-kidney transplant for SIOD 07.07.2022

Schimke immuno-osseous dysplasia (SIOD) is a multisystem disorder that  is inherited in an autosomal recessive pattern. It usually manifests  first with growth failure. Other features of the disease are generally  noted in the ensuing evaluation of the growth failure or develop in the  following years.    Article:  https://www.nejm.org/doi/10.1056/NEJMoa2117028?u...

#8 Marie Passet: Novel high-risk B-cell ALL 08.06.2022

Oncogenic alterations underlying B-cell acute lymphoblastic leukemia  (B-ALL) in adults remain incompletely elucidated. To uncover novel  oncogenic drivers, Marie and her team performed RNA-seq and whole-genome  analyses in a large cohort of unresolved B-ALL. Marie and colleagues  identified a novel subtype characterized by a distinct gene expression  signature and the uni...

#7 Rafal Machowicz: Transplant for HLH 28.04.2022

Hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) is a  rare syndrome of potentially fatal, uncontrolled hyperinflammation.  Allogeneic hematopoietic stem cell transplantation is indicated in  primary, recurrent or progressive HLH, but information about its  outcomes in the adult population is limited. Rafal works at the Department of Hematology, Transplantation...

#6 Madelon de Jong: Myeloma & tumor microenvironment 10.03.2022

Progression and persistence of malignancies are influenced by the local  tumor microenvironment, and future eradication of currently incurable  tumors will, in part, hinge on our understanding of malignant cell  biology in the context of their nourishing surroundings.  Article: https://www.nature.com/articles/s41590-021-00931-3  CONNECT with Trainee Committee https://twitt...

#5 Oscar Brück: Machine learning in histopathology 04.02.2022

Histopathology is elementary in the diagnostics of patients with MDS,  but its high-dimensional data are underused. By elucidating the  association of morphologic features with clinical variables and  molecular genetics, this study highlights the vast potential of  convolutional neural networks in understanding MDS pathology and how  genetics is reflected in BM morphology....

#4 Christopher Gibson: Clonal Hematopoiesis and transplantation 21.01.2022

Clonal hematopoiesis (CH) is an age-related, asymptomatic condition in  which leukemia-associated somatic mutations are detected in the blood of  individuals without a hematologic malignancy. In the nontransplant  setting, CH is uniformly associated with adverse outcomes, including an  elevated risk of developing hematologic malignancies and an increased  risk of nonhemato...

#3 Francesca Tucci: Hurler Syndrome and gene therapy 08.01.2022

Hurler syndrome, also known as mucopolysaccharidosis Type IH (MPS-IH),  Hurler's disease, and formerly gargoylism, is a genetic disorder that  results in the buildup of large sugar molecules called  glycosaminoglycans (GAGs) in lysosomes. The inability to break down  these molecules results in a wide variety of symptoms caused by damage  to several different organ systems,...

#2 Emma Groarke: VEXAS syndrome 05.12.2021

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a recently described autoinflammatory syndrome characterized by diffuse inflammatory manifestations, predisposition to hematological malignancy, and an association with a high rate of thrombosis. VEXAS is attributed to somatic mutations in the UBA1 gene in hematopoietic stem and progenitor cells with myeloid restriction i...

#1 Sushree Sahoo: SAMD9/SAMD9L syndromes 22.11.2021

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Sahoo SS , et al. Nat Med. 2021 Oct;27(10):1806-1817. doi: 10.1038/s41591-021-01511-6

Écoute le podcast Trainee Pearls sur Replaio

La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement

Télécharger sur Google Play

Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics